BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8915817)

  • 1. Treatment of hypercholesterolemia with heparin-induced extracorporeal low-density lipoprotein precipitation (HELP).
    Lees RS; Holmes NN; Stadler RW; Ibrahim SF; Lees AM
    J Clin Apher; 1996; 11(3):132-7. PubMed ID: 8915817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein apheresis using the Liposorber dextran sulfate cellulose system for patients with hypercholesterolemia refractory to medical therapy.
    Gordon BR; Saal SD
    J Clin Apher; 1996; 11(3):128-31. PubMed ID: 8915816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical long-term results of H.E.L.P.-apheresis].
    Schuff-Werner P
    Z Kardiol; 2003; 92(Suppl 3):III28-9. PubMed ID: 14663598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
    Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
    Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One year experience with a low density lipoprotein apheresis system.
    Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
    Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [LDL-apheresis in the treatment of coronary heart disease. Rationale for a specific adjuvant therapy].
    Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III6-27. PubMed ID: 14663597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
    Horstkotte D; Mellwig KP
    Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease.
    Blessing F; Wang Y; Walli AK; Seidel D
    Transfus Apher Sci; 2004 Jun; 30(3):255-66. PubMed ID: 15172631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss.
    Suckfüll M
    Ther Apher; 2001 Oct; 5(5):377-83. PubMed ID: 11778923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis].
    Schuff-Werner P
    Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure.
    Bosch T; Thiery J; Gurland HJ; Seidel D
    Nephrol Dial Transplant; 1993; 8(12):1350-8. PubMed ID: 8159304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [LDL-Apheresis for the treatment of hyperchylomicronemia-induced pancreatitis].
    Sattler AM; Bock K; Schmidt S; Maisch B; Schaefer JR
    Z Kardiol; 2003; 92(Suppl 3):III64-7. PubMed ID: 14663605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmapheresis in familial hypercholesterolemia.
    Thompson GR; Barbir M; Okabayashi K; Trayner I; Larkin S
    Arteriosclerosis; 1989; 9(1 Suppl):I152-7. PubMed ID: 2912429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T; Lennertz A; Schenzle D; Dräger J;
    J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases].
    Mo JK; Li YX; Lei D; Wu DH
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):278-9. PubMed ID: 12390791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct adsorption of lipoproteins from whole blood by direct adsorption of lipoprotein apheresis: first experience in two hypercholesterolemic children.
    Bayrakci US; Besbas N; Ozcebe O; Coskun T; Akgul E; Kutluk T; Bakkaloglu A
    Ther Apher Dial; 2005 Dec; 9(6):469-72. PubMed ID: 16354278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.